Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovascular & pulmonary diseases.
CRNO | ST
Overview
Corporate Details
- ISIN(s):
- SE0008241541 (+3 more)
- LEI:
- 549300VX8KTMYDS6NM84
- Country:
- Sweden
- Address:
- BioVentureHub, 431 83 Mölndal
- Website:
- https://cerenoscientific.com/
- Sector:
- Manufacturing
Description
Cereno Scientific is a clinical-stage biotechnology company developing disease-modifying therapeutics for rare cardiovascular and pulmonary diseases. The company's pipeline focuses on epigenetic modulation and includes a portfolio of Histone Deacetylase (HDAC) inhibitors in clinical development. These candidates are designed to address the root mechanisms of complex diseases. In the preclinical stage, the company is advancing assets such as CS585, a novel prostacyclin (IP) receptor agonist. The strategic focus on rare diseases targets underserved patient populations with significant unmet medical needs, aiming to provide high treatment value and potentially enable shorter development timelines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cereno Scientific AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cereno Scientific AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cereno Scientific AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-16 | Sten Sörensen | Other | Other | 866,665 | 86,666.50 SEK |
| 2024-11-25 | Security Holding Sverige AB | Other | Buy | 20,000 | 99,800.00 SEK |
Peer Companies
